Business Description
Rohto Pharmaceutical Co Ltd
ISIN : JP3982400008
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.45 | |||||
Equity-to-Asset | 0.62 | |||||
Debt-to-Equity | 0.18 | |||||
Debt-to-EBITDA | 1.06 | |||||
Interest Coverage | 171.52 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 4.66 | |||||
Beneish M-Score | -2.39 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 14.4 | |||||
3-Year EBITDA Growth Rate | 19 | |||||
3-Year EPS without NRI Growth Rate | 20.4 | |||||
3-Year FCF Growth Rate | 37.7 | |||||
3-Year Book Growth Rate | 16.5 | |||||
Future 3-5Y EPS without NRI Growth Rate | 8.26 | |||||
Future 3-5Y Total Revenue Growth Rate | 12.1 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 85.19 | |||||
9-Day RSI | 69.55 | |||||
14-Day RSI | 57.88 | |||||
6-1 Month Momentum % | -13.37 | |||||
12-1 Month Momentum % | 2.29 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.84 | |||||
Quick Ratio | 1.29 | |||||
Cash Ratio | 0.58 | |||||
Days Inventory | 156.05 | |||||
Days Sales Outstanding | 60.9 | |||||
Days Payable | 56.09 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.05 | |||||
Dividend Payout Ratio | 0.25 | |||||
3-Year Dividend Growth Rate | 26 | |||||
Forward Dividend Yield % | 1.15 | |||||
5-Year Yield-on-Cost % | 2.55 | |||||
Shareholder Yield % | -0.37 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 57.38 | |||||
Operating Margin % | 13.07 | |||||
Net Margin % | 9.67 | |||||
FCF Margin % | 8.98 | |||||
ROE % | 11.22 | |||||
ROA % | 7.62 | |||||
ROIC % | 10.55 | |||||
ROC (Joel Greenblatt) % | 30.59 | |||||
ROCE % | 14.16 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 24.59 | |||||
Forward PE Ratio | 18.57 | |||||
PE Ratio without NRI | 23.95 | |||||
Shiller PE Ratio | 35.73 | |||||
PEG Ratio | 1.47 | |||||
PS Ratio | 2.38 | |||||
PB Ratio | 2.64 | |||||
Price-to-Tangible-Book | 3.46 | |||||
Price-to-Free-Cash-Flow | 26.48 | |||||
Price-to-Operating-Cash-Flow | 19.57 | |||||
EV-to-EBIT | 17.62 | |||||
EV-to-EBITDA | 15.77 | |||||
EV-to-Revenue | 2.36 | |||||
EV-to-FCF | 24.29 | |||||
Price-to-Projected-FCF | 1.65 | |||||
Price-to-DCF (Earnings Based) | 0.9 | |||||
Price-to-DCF (FCF Based) | 1.25 | |||||
Price-to-Median-PS-Value | 1.21 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.16 | |||||
Price-to-Graham-Number | 1.93 | |||||
Price-to-Net-Current-Asset-Value | 13.57 | |||||
Earnings Yield (Greenblatt) % | 5.68 | |||||
FCF Yield % | 3.77 | |||||
Forward Rate of Return (Yacktman) % | 18.92 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Rohto Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil 円) | 282,053 | ||
EPS (TTM) (円) | 119.15 | ||
Beta | -0.08 | ||
Volatility % | 32.51 | ||
14-Day RSI | 57.88 | ||
14-Day ATR (円) | 69.374907 | ||
20-Day SMA (円) | 2808.725 | ||
12-1 Month Momentum % | 2.29 | ||
52-Week Range (円) | 2638 - 3688 | ||
Shares Outstanding (Mil) | 228.14 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 8 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Rohto Pharmaceutical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Rohto Pharmaceutical Co Ltd Stock Events
Event | Date | Price(円) | ||
---|---|---|---|---|
No Event Data |
Rohto Pharmaceutical Co Ltd Frequently Asked Questions
What is Rohto Pharmaceutical Co Ltd(TSE:4527)'s stock price today?
When is next earnings date of Rohto Pharmaceutical Co Ltd(TSE:4527)?
Does Rohto Pharmaceutical Co Ltd(TSE:4527) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |